Osaic Holdings’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9
| Closed | -$2 | – | 8075 |
|
|
2025
Q2 | $2 | Hold |
9
| – | – | ﹤0.01% | 7727 |
|
|
2025
Q1 | $10 | Sell |
9
-1
| -10% | -$6 | ﹤0.01% | 7378 |
|
|
2024
Q4 | $91 | Buy |
+10
| New | +$133 | ﹤0.01% | 7253 |
|
|
2024
Q1 | – | Sell |
-10
| Closed | -$768 | – | 7491 |
|
|
2023
Q4 | $768 | Buy |
10
+8
| +400% | +$1.2K | ﹤0.01% | 6826 |
|
|
2023
Q3 | $479 | Hold |
2
| – | – | ﹤0.01% | 6997 |
|
|
2023
Q2 | $648 | Hold |
2
| – | – | ﹤0.01% | 6989 |
|
|
2023
Q1 | $471 | Hold |
2
| – | – | ﹤0.01% | 7143 |
|
|
2022
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 7526 |
|
|
2022
Q3 | $1K | Buy |
2
+1
| +100% | +$360 | ﹤0.01% | 7138 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7687 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | +$583 | ﹤0.01% | 7621 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7655 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7378 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7181 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7000 |
|
Osaic Holdings's VRPX Position: Q3 2025 in Review
Osaic Holdings sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q3 2025, closing a stake of 9 shares — an estimated $2 sold.
Osaic Holdings first reported a position in VRPX in Q1 2022 and held it in 11 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold VRPX as of Q3 2025.
- Osaic Holdings reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Osaic Holdings sold 9 Virpax Pharmaceuticals, Inc. Common Stock shares in Q3 2025, an estimated $2.
- Osaic Holdings first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 11 quarters.
- Osaic Holdings's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q3 2022.
- 0 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q3 2025.
Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.